NCT04282317

Brief Summary

The study is to lay the groundwork for non invasive imaging of the GI tract and the brain gut interaction

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Aug 2019Dec 2026

Study Start

First participant enrolled

August 1, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 24, 2020

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

April 12, 2024

Status Verified

April 1, 2024

Enrollment Period

6.4 years

First QC Date

December 19, 2019

Last Update Submit

April 11, 2024

Conditions

Keywords

Gastroparesisfunctional MRIGastric MRIBrain MRI

Outcome Measures

Primary Outcomes (1)

  • Gastric peristalsis

    Compare 3D gastric peristalsis progression before \& after test meals in healthy volunteers and patients with gastroparesis

    Baseline

Secondary Outcomes (2)

  • Contraction frequency

    Baseline

  • Pylorus transit

    Baseline

Study Arms (2)

Healthy Volunteer

OTHER

This arm will enroll healthy volunteers as controls

Other: MRI scan

Gastroparesis Subjects

OTHER

This arm will enroll a) patients with gastroparesis from type 1 diabetes and b) patients with gastroparesis from vagus nerve trauma

Other: MRI scan

Interventions

MRI scan

Gastroparesis SubjectsHealthy Volunteer

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers from 18 to 65 years of age

You may not qualify if:

  • Contraindication to MR scanning: pregnancy, implanted gastric stimulator, neural stimulator, implanted cardiac pacemaker, auto-defibrillator, cochlear implant, ocular foreign body (e.g. metal shavings), pain pump, insulin pump or any pre-existing eye conditions.
  • Presence of gastroparesis symptoms, such as nausea, emesis, early satiety, effortless regurgitation, post-prandial fullness and pain, and/or postprandial epigastric pain.
  • Prior diagnosis of the upper GI disorders, including gastroparesis, gastric or duodenal ulcer, gastric outlet obstruction, acute or chronic pancreatitis, large hiatal or paraesophageal hernia, small intestinal bacterial overgrowth, celiac disease, Crohn's disease.
  • Prior systemic disorders associated with GI neuromuscular disorder listed in Appendix B.
  • Taking medications that can effect GI motility, including opiate, metoclopramide, dopamine agonist for Parkinson or restless leg syndrome, anticholinergics.
  • Prior brain or abdominal surgery (except cholecystectomy or appendectomy).
  • Prior diagnosis of central nervous system illness, neurological lesion, a psychiatric history, or recurrent migraines that require medication.
  • Uncontrolled medical problems, such as hypertension, pulmonary or airway disease, heart failure, or coronary artery disease.
  • Allergy to pineapple.
  • Presence of dysphagia.
  • Unable to give own informed consent.
  • GASTROPARESIS PATIENTS
  • Patients with gastroparesis from 18 to 65 years of age.
  • Symptoms of gastroparesis of at least 12 weeks duration with varying degrees of nausea, emesis, early satiety, effortless regurgitation, post-prandial fullness and pain, and/or postprandial epigastric pain.
  • Abnormal 4-hour gastric emptying scintigraphy within the last 6 months \>60% retention at 2 hrs and/or \>10% retention at 4 hrs.
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University School of Medicine

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Conditions

Gastroparesis

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • John M Wo, MD

    Indiana University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of GI Motility and Neurogastroenterology Unit

Study Record Dates

First Submitted

December 19, 2019

First Posted

February 24, 2020

Study Start

August 1, 2019

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

April 12, 2024

Record last verified: 2024-04

Locations